Načítá se...
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
Most research on fluid biomarkers for central nervous system (CNS) disorders has so far been performed using cerebrospinal fluid (CSF) as the biomarker source. CSF has the advantage of being closer to the brain than serum or plasma with a relative enrichment of CNS-specific proteins that are present...
Uloženo v:
| Vydáno v: | Alzheimers Dement (Amst) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941042/ https://ncbi.nlm.nih.gov/pubmed/27453931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.05.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|